Johnson & Johnson, the New Brunswick, N.J., health-care products major, reported fourth-quarter net income slumped 89% on 3.9% higher sales
Earnings fell to $218 million, or 8 cents a share, from $1.94 billion, or 70 cents, in the year-earlier quarter
Excluding special items, adjusted earnings per share were $1.13, up 9.7%
Sales reached $16.26 billion from $15.64 billion
A survey of analysts by FactSet Research produced consensus estimates of $1.09 a share of profit on $16.28 billion of revenue
For 2012, J&J estimated it would earn $5.05 to $5.15 a share excluding special items
FactSet's view: $5.20
No hay comentarios:
Publicar un comentario